Skip to main content
Log in

VLCAD enzyme activity determinations in newborns identified by screening: a valuable tool for risk assessment

  • Original Article
  • Published:
Journal of Inherited Metabolic Disease

Abstract

Tandem mass spectrometry-based newborn screening correctly identifies individuals with very long-chain acyl-CoA dehydrogenase deficiency (VLCADD). However, a great number of healthy individuals present with identical acylcarnitine profiles during catabolism in the first three days of life. We routinely perform an enzyme activity assay as confirmation analysis in newborns identified by screening. Whereas VLCAD residual activities of less than 10% are clearly diagnostic and indicate patients at risk of clinical disease, the clinical relevance of higher residual activities is unclear. In this study we assess the molecular basis in 34 individuals with residual activities of 10-50%. We identify two pathogenic mutations in patients that result in residual activities as high as 22%, while individuals with residual activities of 25-50% either present with a heterozygous or no mutation in the VLCAD gene. In addition, confirmed heterozygous parents present with residual activities as low as 32%.

In conclusion, we identify individuals with 2 pathogenic mutations and those with only one heterozygous mutation in the residual activity range of 20-30%. Whereas heterozygosity is generally regarded as clinically irrelevant, identification of 2 VLCAD mutations leads to precautions in the management of the children. Based on our data we anticipate that individuals with a residual enzyme activity >20% present with a biochemical phenotype but likely remain asymptomatic throughout life. Studies in greater patient numbers are needed to correlate residual activities >10% with the genotype and the outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Andresen BS, Bross P, Vianey-Saban C et al. (1996) Cloning and characterization of human very-long-chain Acyl-CoA dehydrogenase cDNA,. chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene. Hum Mol Genet 5:461–472

    Article  PubMed  Google Scholar 

  • Andresen BS, Olpin S, Poorthuis BJHM et al. (1999) Clear correlation of genotype with disease phenotype in very-long-chain Acyl-CoA dehydrogenase deficiency. Am J Hum Genet 64:479–494

    Article  PubMed  CAS  Google Scholar 

  • Dipple KM, McCabe ERB (2000a) Modifier genes convert "simple" mendelian disorders to complex traits. Mol Genet Metab 71:43–50

    Article  PubMed  CAS  Google Scholar 

  • Dipple KM, McCabe ERB (2000b) Phenotypes of patients with "simple" mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics. Am J Hum Genet 66:1729–1735

    Article  PubMed  CAS  Google Scholar 

  • Dipple KM, Phelan JK, McCabe ERB (2001) Consequences of complexity within biological networks: robustness and health, or vulnerability and disease. Mol Genet Metab 74:45–50

    Article  PubMed  CAS  Google Scholar 

  • Gregersen N, Andresen BS, Corydon MJ et al. (2001) Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype - phenotype relationship. Hum Mutat 18:169–189

    Article  PubMed  CAS  Google Scholar 

  • Gregersen N, Andresen B, Pedersen C, Olsen R, Corydon T, Bross P (2008) Mitochondrial fatty acid oxidation defects - remaining challenges. J Inherit Metab Dis 31:643–657

    Article  PubMed  CAS  Google Scholar 

  • Liebig M, Schymik I, Mueller M et al. (2006) Neonatal screening for very long-chain Acyl-CoA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels. Pediatrics 118:1065–1069

    Article  PubMed  Google Scholar 

  • Lindner M, Hoffmann G, Matern D (2010) Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting. J Inherit Metab Dis 33:521–526

    Article  PubMed  CAS  Google Scholar 

  • Maier EM, SrW G, Kemter KF et al. (2009) Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening. Hum Mol Genet 18:1612–1623

    Article  PubMed  CAS  Google Scholar 

  • Mathur A, Sims HF, Gopalakrishnan D et al. (1999) Molecular heterogeneity in very-long-chain Acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death. Circulation 99:1337–1343

    PubMed  CAS  Google Scholar 

  • McAndrew RP, Wang Y, Mohsen AW, He M, Vockley J, Kim JJ (2008) Structural basis for substrate fatty acyl chain specificity. J Biol Chem 283:9435–9443

    Article  PubMed  CAS  Google Scholar 

  • McGoey RR, Marble M (2011) Positive newborn screen in a normal infant of a mother with asymptomatic very long-chain Acyl-CoA dehydrogenase deficiency. J Pediatr 158:1031–1032

    Article  PubMed  Google Scholar 

  • Pons R, Cavadini P, Baratta S et al. (2000) Clinical and molecular heterogeneity in very-long-chain acyl-coenzyme a dehydrogenase deficiency. Pediatr Neurol 22:98–105

    Article  PubMed  CAS  Google Scholar 

  • Roe DS, Vianey-Saban C, Sharma S, Zabot MT, Roe CR (2001) Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype. 312: 55–67

  • Schymik I, Liebig M, Mueller M et al. (2006) Pitfalls of neonatal screening for very-long-chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry. J Pediatr 149:128–130

    Article  PubMed  CAS  Google Scholar 

  • Shekawat PS, Matern D, Strauss AW (2005) Fetal fatty acid oxidation disorders, their effect on maternal health and neonatal outcome: impact of expanded newborn screening on their diagnosis and management. Review 57(5 Pt 2):78R–86R

    Google Scholar 

  • Smith EH, Thomas C, McHugh D et al. (2010) Allelic diversity in MCAD deficiency: The biochemical classification of 54 variants identified during 5 years of ACADM sequencing. Mol Genet Metab 100:241–250

    Article  PubMed  CAS  Google Scholar 

  • Souri M, Aoyama T, Yamaguchi S, Hashimoto T (1998) Relationship between structure and substrate-chain-length specificity of mitochondrial very-long-chain acyl-coenzyme A dehydrogenase. Eur J Biochem 257:592–598

    Article  PubMed  CAS  Google Scholar 

  • Spiekerkoetter U, Sun B, Zytkovicz T, Wanders R, Strauss AW, Wendel U (2003) MS/MS-based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiency. J Pediatr 143:335–342

    Article  PubMed  Google Scholar 

  • Spiekerkoetter U, Lindner M, Santer R et al. (2009) Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis 32:498–505

    Article  PubMed  CAS  Google Scholar 

  • Spiekerkoetter U, Haussmann U, Mueller M et al. (2010) Tandem Mass Spectrometry Screening for Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: The Value of Second-Tier Enzyme Testing. J Pediatr 157:668–673

    Article  PubMed  CAS  Google Scholar 

  • Veale EL, Rees KA, Mathie A, Trapp S (2010) Dominant negative effects of a non-conducting TREK1 splice variant expressed in brain. J Biol Chem 285:29295–29304

    Article  PubMed  CAS  Google Scholar 

  • Vianey-Saban C, Divry P, Brivet M et al. (1998) Mitochondrial very-long-chain acyl-coenzyme A dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta 269:43–62

    Article  PubMed  CAS  Google Scholar 

  • Vockley J, Rinaldo P, Bennett MJ, Matern D, Vladutiu GD (2000) Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways. Mol Genet Metab 71:10–18

    Article  PubMed  CAS  Google Scholar 

  • Wanders R, Vreken P, den Boer M, Wijburg F, Van Gennip A, IJlst L (1999) Disorders of mitochondrial fatty acyl-CoA beta-oxidation. J Inherit Metab Dis 22:442–487

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lars Hoffmann.

Additional information

Communicated by: Bridget Wilcken

Competing interest: None declared.

Lars Hoffmann and Ulrike Haussmann contributed equally to this work.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(DOC 36 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hoffmann, L., Haussmann, U., Mueller, M. et al. VLCAD enzyme activity determinations in newborns identified by screening: a valuable tool for risk assessment. J Inherit Metab Dis 35, 269–277 (2012). https://doi.org/10.1007/s10545-011-9391-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-011-9391-8

Keywords

Navigation